#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Carcinoid syndrome Hepatic angiosarcoma Choroidal dystrophy Hereditary hypophosphataemic rickets Dementia Acute myeloid leukaemia refractory Li-Fraumeni syndrome Primary myelofibrosis Malformation venous Glycogen storage disease type II Complex regional pain syndrome Brain injury Acquired haemophilia VEXAS syndrome Arginase deficiency More trials…

    Learn about Rare Diseases

    Vascular malformation Mucopolysaccharidosis II Haemolytic uraemic syndrome – Treatment Netherton’s syndrome Mantle cell lymphoma stage III – Basic Information Sjogren’s syndrome – Basic Information Lennox-Gastaut syndrome – Basic Information Prader-Willi syndrome – Trials in Disease Hereditary ataxia – Treatment Waldenstrom’s macroglobulinaemia More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Calcium Chloride Mps-214 Atezolizumab Lysine Aspirin Vancomycin Hydrochloride Corylus Avellana L. Anhydrous Benzoyl Peroxide FLUCLOXACILLIN SODIUM Metformin Hydrochloride Mecasermin Rinfabate Enlicitide Chloride L-Tryptophan Floxuridine Ligelizumab LUMC-BOB1-B7-TCR.1 Deutivacaftor SIGVOTATUG VEDOTIN Ucart22 Piperacillin Cinnarizine More therapies…

    Learn about Your Condition

    Asthma Cardiac amyloidosis Spinal cord injury Obstructive airways disorder Arterial disorder Anal cancer metastatic Follicular lymphoma stage II Anxiety disorder Inguinal hernia Endometrial stromal sarcoma Procedural headache Anal cancer recurrent Meningioma malignant Hyperthyroidism Retroperitoneal cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Non-small cell lung cancer

  • Study of Nivolumab and Ipilimumab with Chemotherapy for Patients with Stage IV Non-Small Cell Lung Cancer and Brain Metastases

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    Spain

  • Study on the Safety and Effects of ATL001 and Pembrolizumab in Adults with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Adenosquamous cell lung cancer recurrent
    • Adenosquamous cell lung cancer stage III
    • Adenosquamous cell lung cancer stage IV
    Investigated Drugs:
    • Atl001
    • Pembrolizumab
    France Germany Spain

  • Study of Datopotamab Deruxtecan, Durvalumab, and Carboplatin for Advanced Non-Small Cell Lung Cancer in Patients Without Actionable Genomic Alterations

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Datopotamab Deruxtecan
    Austria Bulgaria France Germany Greece Hungary +4

  • Study of Durvalumab with Radiation Therapy for Patients with Early Stage Non-Small Cell Lung Cancer and Osimertinib for Those with EGFR Mutation

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Glucose
    • Osimertinib
    • Durvalumab
    Belgium France Germany Greece Italy The Netherlands +2

  • Study of Tiragolumab, Atezolizumab, and Pembrolizumab for Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer

    Not recruiting

    4 1 1
    Investigated Drugs:
    • Tiragolumab
    • Atezolizumab
    • Pembrolizumab
    Belgium Denmark France Germany Poland Spain

  • Study of SKB264 and Pembrolizumab for Treating Patients with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Cimetidine Hydrochloride
    • Magnesium Hydroxide
    • Nizatidine
    Romania Spain
Previous Page
1 … 38 39 40 41 42 … 54
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!